Aortica Completes $7M Series A Financing

Aortica Corporation, a Kirkland, Wash.-based company focused on the development of innovative treatments for abdominal aortic aneurysms (AAA), completed a $7m Series A financing.

The company intends to use the funds to complete its IDE pivotal study.

Led by president and CEO Tom Douthitt, a medical device industry veteran with 28 years of experience, and co-founder and Chief Medical Officer Dr. Ben Starnes, Aortica was founded to design, manufacture, and market tools for treatment of patients with AAA disease who have aortic anatomy that limits their treatment options. The company has developed a “patient-specific” solution by combining a patient’s CT scans with its proprietary software and 3D printing to customize a standard endograft to fit precisely and anchor securely within each patient.



Join the discussion